Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial

Elisa Gremese, Florenzo Iannone, Giovanni La Montagna, Gianfilippo Bagnato, Annarita Giardina, Giovanni Lapadula

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
Original languageEnglish
Pages (from-to)286-292
Number of pages7
JournalTHE JOURNAL OF RHEUMATOLOGY
Volume41
DOIs
Publication statusPublished - 2014

Keywords

  • Adult
  • Aged
  • Alanine Transaminase
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Aspartate Aminotransferases
  • DISEASE ACTIVITY SCORE
  • Drug Therapy, Combination
  • Female
  • GISEA
  • HEALTH ASSESSMENT QUESTIONNAIRE
  • Hepacivirus
  • Hepatitis C
  • Humans
  • Immunoglobulin G
  • Liver Function Tests
  • Male
  • Methotrexate
  • Middle Aged
  • Prospective Studies
  • Receptors, Tumor Necrosis Factor
  • Severity of Illness Index
  • TNF-α INHIBITORS
  • TRANSAMINASES
  • Treatment Outcome
  • Viral Load
  • Virus Replication

Fingerprint

Dive into the research topics of 'Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial'. Together they form a unique fingerprint.

Cite this